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Introduction
Congenital myopathies are a heterogeneous group of muscle 
disorders that usually become evident at birth or early infancy. 
Molecular analysis and studies of animal models have broad-
ened our knowledge of the causes and pathophysiology of these 
diseases immensely (D’Amico and Bertini, 2008; Sewry, 2008). 
The zebrafish embryo has proven particularly useful for identi-
fying genes that are required to build and maintain the muscle 
apparatus, offering insights into the underlying mechanisms and 
providing gene candidates and models for human myopathies 
(Bassett and Currie, 2004; Behra et al., 2004; Deniziak et al.,   
2007; Guyon et al., 2007; Flinn et al., 2008; Hawkins et al., 
2008; Ingham, 2009). In contrast to humans and mice, zebrafish 
embryos deficient in proteins of the dystrophin–glycoprotein 
complex  (DGC),  such  as  dystrophin,  dystroglycan,  delta-
sarcoglycan, and the fukutin-related protein (FKRP), already 
show phenotypes during embryonic stages. These mutants have 
impaired motility and exhibit a curved body, U-shaped somites, 
and myofibrils that detach from the vertical myosepta, a connec-
tive tissue that separates somites and is functionally equivalent 
to the mammalian tendon (Parsons et al., 2002; Bassett et al., 
2003; Guyon et al., 2003a,b, 2005, 2009; Kudo et al., 2004; 
Hall et al., 2007; Thornhill et al., 2008). In addition, other pro-
teins,  such  as  obscurin  or  the  TGF-–related  factor  Mstn2, 
have been shown in the zebrafish to influence the expression 
or organization of the DGC, resulting in dystrophic phenotypes 
(Raeker et al., 2006; Amali et al., 2008).
The  chaperones  Unc45  and  Hsp90  are  necessary  for 
proper  myosin  folding  (Barral  et  al.,  2002;  Srikakulam  and 
Winkelmann, 2004; Etard et al., 2007; Hawkins et al., 2008). 
Mutations in zebrafish unc45b or hsp90a result in paralyzed 
animals that fail to form myofibrils in skeletal and cardiac mus-
cles (Etard et al., 2007; Hawkins et al., 2008). Unc45 and Hsp90 
form complexes with myosin that are required for proper fold-
ing and assembly of myosin into thick filaments (Barral et al., 
1998, 2002; Srikakulam and Winkelmann, 2004; Etard et al., 
2007,2008; Hawkins et al., 2008). The subcellular distribution 
of the two chaperones is highly dynamic: Unc45b and Hsp90a 
associate transiently with nascent myosin and locate to the   
Z line once the fibril has formed in zebrafish muscle (Etard 
et al., 2008). Damage to the myofiber causes a shift of the 
two chaperones to the A band, which suggests that the Z line 
serves as a reservoir for myosin chaperones (Etard et al., 2008). 
The stability of UNC-45 in Caenorhabditis elegans is tightly 
regulated via complex formation with the ubiquitin ligase   
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two somites. These phenotypes are shared with unc45b mu-
tants. Our data suggest that the Apo2 proteins and Unc45b act in 
a developmental pathway, which is required for the integrity of 
the myosepta and for myofiber attachment.
Results
Unc45b interacts with Apo2a
In a two-hybrid screen using the full-length zebrafish Unc45b 
as the bait, an interacting protein with sequence similarity to the 
mammalian C-to-U deaminase Apo2 (Fig. S1 A) was identified 
five times, in addition to five other proteins including Hsp90 
proteins (Materials and methods; Etard et al., 2007). We refer to 
this protein as Apo2a. To determine whether the observed inter-
action in the yeast assay merited follow-up studies, we performed 
in vitro pull-down experiments with recombinant proteins pro-
duced in Escherichia coli and in situ expression analysis in the 
zebrafish embryo to assess whether unc45b and apo2a are 
expressed in the same cells.
Pull-down experiments were performed with in vivo and 
in vitro translated GST-Apo2a and Unc45b-GFP chimeras, re-
spectively, in which Apo2a and Unc45b were fused in-frame 
with GST and GFP. The results confirmed the interaction ob-
served in the yeast two-hybrid experiments: GST-Apo2a pulled 
down Unc45b-GFP as revealed by Western blotting with an anti-
GFP antibody (Fig. 1, A–C, lane 1).
Unc45b protein contains three domains with different 
functions, namely a tetratricopeptide repeat (TPR) domain nec-
essary for interaction with the cochaperone Hsp90; a Unc45-/ 
Cro1p-/She4p-related (UCS) domain, which binds to myosin 
motor domain; and a central domain that mediates Z line as-
sociation (Etard et al., 2008). To determine which domain of 
Unc45b is required for interaction with Apo2a, Unc45b dele-
tions (Fig. 1, A and B) were tested in pull-down assays. The 
results show that both the UCS and the central domain have 
the ability to interact with Apo2a (Fig. 1 C, lanes 2–4 and 6). 
In contrast, the TPR-GFP fusion protein did not interact with 
Apo2a (Fig. 1 C, lane 5). GFP alone, without attached Unc45b 
sequences, was also not pulled down by the GST-Apo2a chimera 
(Fig. 1 E, lane 10). These results demonstrate that the binding to 
Apo2a requires the UCS and central domains of Unc45b and is 
not mediated by interaction with the TPR domain or GFP. In ad-
dition, we tested whether the related chaperone Unc45a that is 
required for blood vessel formation in the zebrafish (Anderson 
et al., 2008) can also bind Apo2a in the in vitro binding assay. 
However, we did not detect an interaction between Apo2a and 
Unc45a (unpublished data).
Unc45b forms complexes with other chaperones such as 
members of the Hsp90 family (Barral et al., 2002; Etard et al., 
2007). We therefore investigated whether Apo2 proteins could 
also bind to Hsp90a. GST-Apo2a did not pull down Hsp90a-
GFP (Fig. 1, D and E, lane 11). The closely related Hsp90a2 
and Hsp90b proteins also did not interact with Apo2a in this in 
vitro pull-down assay (unpublished data). Collectively, these 
results suggest that Apo2a does not bind Hsp90 chaperones. 
Furthermore, this underscores the notion that Apo2a interacts 
with Unc45b in a specific manner.
C terminus of Hsp70-interacting protein (CHIP; Hoppe et al., 
2004; Nyamsuren et al., 2007), an interaction that has been 
linked with late-onset hereditary inclusion-body myopathies in 
humans (Janiesch et al., 2007).
To systematically explore the role of Unc45b in zebrafish 
and to identify additional candidates for human disease genes, 
we have performed a two-hybrid screen with Unc45b as bait. 
Here, we describe an interaction between Unc45b and Apobec2 
(Apo2). Apo2 belongs to a small family of structurally related 
proteins (Wedekind et al., 2003). Apo1, the founding member 
of this family, edits apolipoprotein mRNA by deaminating a 
cytosine to uracil (Teng et al., 1993; Yamanaka et al., 1994; 
Wedekind et al., 2003). This introduces a stop codon, generat-
ing two forms of apolipoprotein B (apoB), transporters of cho-
lesterol and triglyceride (Knott et al., 1986). Members of the 
Apo3 subfamily play critical roles in retroviral defense (Harris 
et al., 2003; Mangeat et al., 2003). Apo3 proteins bind HIV-1 
RNA and physically impede movement of the reverse transcrip-
tion on the viral template in a cytidine-deaminase–independent 
manner. In addition, the reverse-transcribed minus strand was   
shown  to  be  a  target  for  the  deaminase  activity  of Apo3G 
(Yu et al., 2004). The related activation-induced (cytidine) de-
aminase enzyme (AID) is expressed in the germinal centers of 
lymph nodes that contain activated B cells, and is essential for 
the somatic hypermutations that diversify the variable regions 
of immunoglobulin genes (Muramatsu et al., 1999, 2000).
In contrast to these members of the Apo family, little is 
known about either the specific substrates or the physiological 
functions of Apo2 (Liao et al., 1999; Anant et al., 2001). The 
deaminase activity of Apo2 itself is discussed controversially: 
some have claimed there is a low but intrinsic cytidine deami-
nase activity (Liao et al., 1999), whereas others regard this de-
aminase activity as a contamination with deaminases from the 
bacterial host used to produce the protein (Mikl et al., 2005). 
Expression of apo2 was originally reported to be restricted to 
cardiac and skeletal muscles (Liao et al., 1999; Mukhopadhyay   
et al., 2002), but a recent analysis using a cDNA panel derived 
from different tissues showed ubiquitous expression at a low 
level in human and mouse (Matsumoto et al., 2006). Apo2 ex-
pression is strongly enhanced in the liver in response to both 
tumor necrosis factor and interleukin- via a nuclear factor β 
response element in the promoter. This suggests a role of Apo2 
in the physiopathology of hepatic inflammation (Matsumoto 
et al., 2006). However, a function of Apo2 in the skeletal or car-
diac muscles has not been demonstrated (Mikl et al., 2005).
In contrast to the situation in mammals, only two mem-
bers of the Apo2 subfamily and one homologue of AID are de-
tectable in the zebrafish genome, which suggests that they are 
the most ancient members of the family and that Apo1 and Apo3 
emerged later in the evolution of the vertebrate lineage (Liao   
et al., 1999; Conticello et al., 2005; Mikl et al., 2005). In this 
study, we show that the two related zebrafish members of the Apo2 
subfamily (called Apo2a and Apo2b) interact with Unc45b. This 
interaction is specific for Unc45b. Morpholino oligonucleotide–
mediated knockdown of translation of apo2a or apo2b mRNA 
resulted in a dystrophic phenotype with cell-free spaces in 
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knockdown of Apo2a resulted in reduced birefringence of 
the skeletal musculature, which is an indication of a disturbed   
arrangement of muscle fibers and/or fibrils. Impaired mobility 
was correlated with a significant reduction of birefringence 
on the flanks of the morphants, which indicates disorganized 
myofibrils (Fig. 3, B–D; 70% of morphants, n = 100). Mor-
phant embryos developed pericardial edema (Fig. 3 O) asso-
ciated with a slightly decreased heart rate compared with 
wild-type (Fig. 3 N, n = 20 for both morphant and control em-
bryos). The Mo(ATG)-apo2a–injected embryos also showed 
brain necrosis, which is a frequent nonspecific effect of morpho-
lino injections (Robu et al., 2007). Necrosis was completely 
abolished when a morpholino directed against p53 (Mo-p53; 
Robu et al., 2007) was coinjected. Mo-p53 alone did not af-
fect the muscle birefringence or induce pericardial edema 
(Fig. 3, K and L; and not depicted), which suggests that the car-
diac and skeletal defects are indeed specific for the injected 
Mo(ATG)-apo2a.
To further prove that the effects of the injected Mo(ATG)-
apo2a are specific for the apo2a mRNA and that the observed 
phenotypes are caused by a lack of Apo2a function, we performed 
several additional controls. First, we coinjected a plasmid encod-
ing a fusion protein of Apo2a and GFP. Co-injection of the 
Mo(ATG)-apo2a strongly reduced expression of this Apo2a–GFP 
fusion protein as measured by reduced GFP fluorescence (Fig. 3, 
H and I). Second, we designed a mismatch morpholino (Mo(ATG)-
apo2a-cont) that contained five mismatches compared with the 
Mo(ATG)-apo2a. Injection of this morpholino did not show any 
phenotypes (Fig. 3 L and not depicted) and it did not block 
Apo2a-GFP expression (Fig. 3 J). Finally, another morpholino 
Apo2a is coexpressed with unc45b  
in skeletal and cardiac muscle
Unc45b is exclusively expressed in skeletal and cardiac muscles 
of the zebrafish embryo (Etheridge et al., 2002; Etard et al., 
2007). We next assessed whether the apo2a gene is transcribed 
in the same tissues. Whole mount in situ hybridization showed 
that apo2a mRNA is expressed strongly in all skeletal muscles 
of the trunk and the head as well as in the heart (Fig. 2, A–F). 
Expression was detected as early as the 18-somite stage in the 
developing somitic musculature (Fig. 2 A). At 24 hours post-
fertilization (hpf), apo2a transcripts are evident in the heart and 
in the somites (Fig. 2, B and C). At later stages, expression of 
apo2a becomes apparent in the musculature of the head, as well 
as in that of the pectoral fins (Fig. 2, D–F). We did not detect 
expression in tissues other than the cardiac and skeletal muscu-
lature, although we cannot exclude low-level expression in 
other tissues below the detection limit of the assay used. This 
pattern of cell-specific mRNA expression is directly compara-
ble to that of unc45b (Etard et al., 2007).
Apo2a is necessary for muscle integrity
To investigate whether Apo2a has a function in the develop-
ment or maintenance of the muscle apparatus, the translation 
of apo2a was blocked by injection of a morpholino oligo-
nucleotide (Mo[ATG]-apo2a) directed against a 25-bp mRNA 
region surrounding the start codon (Fig. 3 A). Morpholino- 
injected embryos showed impaired motility, in that embryos 
twitched and contracted upon touch stimulation but failed to 
escape (70.3% of morpholino-injected embryos [“morphants,” 
n = 100]). Next, we assessed whether morpholino-mediated 
Figure  1.  Apo2a  interacts  with  Unc45b  but 
not Hsp90a in pull-down assays. (A) Schematic 
representation of the full-length Unc45b protein 
fused  to  GFP.  Unc45b  is  composed  of  three   
domains:  the  TPR  (amino  acids  1–119),  the 
central (amino acids 120–509), and the UCS 
(amino  acid  910–935)  domains.  The  intact 
Unc45b protein and its subdomains as well as 
Hsp90a were fused at their C terminus to GFP 
and used as input protein in the pull-down assays 
as  indicated.  (B)  In  vitro  synthesized  chimeric 
proteins visualized by Western blotting with anti-
GFP antibody. (C) Full-length Unc45b-GFP fusion 
protein (lane 1) and deletion variants of Unc45b 
fused to GFP (TPR-deleted Unc45b [Unc45-TPR] 
lane 2; UCS-deleted Unc45b [Unc45b-UCS], 
lane 3; or single Unc45b domains fused to GFP 
[Unc45b-Central], lane 4; Unc45b-TPR, lane 5; 
Unc45b-UCS, lane 6) were pulled down with 
the GST-Apo2a fusion protein. With the excep-
tion of Unc45b-TPR (lane 5), all other chimeras 
were pulled down by GST-Apo2a fusion proteins 
(lanes 1–4 and 6). (D) Western blot of protein 
input of Hsp90a-GFP fusion (lane 11). Unc45b-
UCS (lane 8), Unc45b-TPR (lane 9), and GFP 
(lane 10) were used as positive and negative 
controls, respectively, to test for an interaction of 
GST-Apo2a with Hsp90a-GFP. Note that relative 
to protein inputs in binding assays (C and E), 
10-fold less protein was loaded onto the con-
trol gels shown in B and D. White lines indicate 
that  intervening  lanes  have  been  spliced  out.   
(E) Although Unc45b-UCS interacted with Apo2a (lane 8), neither the Unc45b-TPR fusion (lane 9), GFP alone (lane 10), nor Hsp90a-GFP (lane 11) were 
pulled down by GST-Apo2a. Thus, the interaction of Apo2a with Unc45b is specific. Lane 7 and 12 show protein markers. White boxes indicate 95 kD.JCB • VOLUME 189 • NUMBER 3 • 2010   530
(Fig. 4, A and B) in the skeletal muscles at 72 hpf. These 
myofiber-free spaces were restricted to individual somites in 
some cases (Fig. 4 A). In other instances, they spanned two 
somites (Fig. 4 B). Morphant embryos displayed irregular and 
discontinuous myosepta that were locally interrupted with myo-
fibers extending over two adjacent somites (Fig. 4 C; 100%, 
n = 20 embryos). None of these defects were seen in control 
morpholino-injected embryos (100%, n = 60).
The disruptions of the myotome boundary as well as the 
formation of myofiber-free spaces in the somite resembles the 
phenotype of dystrophic mutants (Bassett et al., 2003; Guyon 
et al., 2003b, 2005; Cheng et al., 2006). This prompted us to ex-
amine in more detail the consequence of Apo2a depletion on the 
expression of the DGC. -Dystroglycan is highly enriched in 
(Mo(UTR)-apo2a) directed to sequences in the 5 untranslated 
region (UTR) distinct from those covered by Mo(ATG)-apo2a 
(Fig. 3 A) was designed. Injection of Mo(UTR)-apo2a recapitu-
lated the effects of the Mo(ATG)-apo2a, such as pericardial 
edema and reduced birefringence of the skeletal musculature 
(Fig. 3, E–G). Moreover, Mo(UTR)-apo2a did not cause necrosis 
in the brain, obviating the need to co-inject Mo-p53. Collectively, 
these results demonstrate that the observed phenotypes result 
from a specific knockdown of apo2a mRNA translation.
Loss of Apo2a causes disruption  
of myosepta and myofibers
Examination  of  apo2a  morphants  with  differential  interfer-
ence contrast (DIC) optics revealed abnormal cell-free spaces   
Figure 2.  Apo2a is expressed in the heart and in 
the skeletal musculature. (A–C) In situ hybridization 
with an apo2a anti-sense probe to 18 somites (A) 
and  24-hpf  (B  and  C)  embryos  showing  apo2a 
mRNA expression in cardiac (h) and skeletal mus-
cles (s). (D–F) At 48 (D and E) and 60 hpf (F), the 
expression  was  found  in  the  somitic  muscle   
(s; E and F), hypaxial muscles (hy; F), the pectoral 
fin muscles (pf; E), and cranial muscles (adductor 
mandibulae [am], adductor hyomandibulae [ah], 
sternohyoideus [sh], constrictor hyoideus ventralis 
[chv], and inferior oblique [io]; D and E). The orien-
tation of embryos in the images is anterior to the left 
and are as follows: (A) dorso-lateral view; (B, C, 
and E) lateral view, dorsal up; (D) ventral view; and 
(F) dorsal view. Bars, 200 µm.
Figure 3.  Apo2a morphants have defects in the skeletal mus-
culature and the heart. (A) Position of the morpholinos Mo(ATG)-
apo2a (ATG) and Mo(UTR)-apo2a (UTR) on the apo2a mRNA. 
(B–D) Mo(ATG)-apo2a (B and D) and control Mo(ATG)-apo2a-
cont (harboring five mismatches relative to the Mo(ATG)-apo2a 
sequence; C)-injected embryos. The morphants exhibit a curved 
body axis (B) and show reduced birefringence (D) compared with 
controls  (C).  Note  that  the  Mo(ATG)-apo2a–injected  embryos   
(B and D) were coinjected with the Mo-p53 to suppress unspecific 
effects (see K–M for additional controls for Mo-p53 injection). 
(E–G) Mo(UTR)-apo2a (E and G)- and control Mo(ATG)-apo2a-
cont (F)-injected embryos. The morphants exhibit a curved body 
axis  (E)  and  show  reduced  birefringence  (G)  compared  with 
controls (F). (H–J) Apo2a-GFP expression (H) in embryos injected 
with an apo2a-gfp encoding plasmid. Co-injection of Mo(ATG)-
apo2a with the apo2a-gfp plasmid abolishes Apo2a-GFP expres-
sion (I), whereas coinjection of the apo2a-gfp plasmid with the 
five-mismatch Mo(ATG)-apo2a-cont does not abolish Apo2a-GFP 
expression (J). (K–M) Uninjected (K), Mo(ATG)-apo2a-cont– and 
Mo-p53–coinjected  (L),  and  Mo(ATG)-apo2a–  and  Mo-p53– 
coinjected  embryos  (M).  Injection  of  Mo(ATG)-apo2a  morpho-
lino reduces birefringence (M), whereas neither the five-mismatch 
Mo(ATG)-apo2a-cont nor the Mo-p53 had an effect on the birefrin-
gence of the musculature (L). (N) Mo(ATG)-apo2a and Mo(UTR)-
apo2a morphants have a decreased heart rate (the graph shows 
heart beats per minute, n = 20 embryos). Black bars represent 
standard deviation. The datasets were pairwise subjected to the 
Student’s t test. The difference between the heart rate of Mo(ATG)-
apo2a versus Mo(UTR)-apo2a was not significant (P = 0.220), 
whereas the difference between the heart rate of Mo(ATG)-apo2a 
versus control or Mo(UTR)-apo2a versus control was highly significant (P = 0.002 and P = 0.003, respectively). (O) Pericardial edema (arrow) in a 
Mo(ATG)-apo2a– and Mo-p53–coinjected embryo. Embryos shown are 72 hpf, except F–H, which show 24-hpf embryos. Pigmentation of the embryo 
shown in E was suppressed by 1-phenyl 2-thiourea (PTU) treatment (Karlsson et al., 2001). Bars, 80 µm.531 Lack of Apobec2 causes dystrophy • Etard et al.
regularly packed, the fast muscle fibers appeared twisted and 
less well stacked in the morphants (Fig. 4, L and M).
Like the Mo(ATG)-apo2a morphants, embryos injected 
with Mo(UTR)-apo2a (directed to the 5 UTR of apo2a mRNA; 
see above, Fig. 3 A) showed gaps between myofibers, detached 
fibers, and giant fibers extending across two somites (not de-
picted). Collectively, we conclude that Apo2a is required for 
muscle integrity. Importantly, knockdown embryos displayed 
phenotypes that are identical to those observed in zebrafish 
models of human muscular dystrophies (Parsons et al., 2002; 
Bassett et al., 2003; Bassett and Currie, 2004; Thornhill et al., 
2008; Guyon et al., 2009).
Apo2b is necessary for muscle integrity
A search of the zebrafish genome uncovered another related apo 
gene that we named apo2b. The two proteins share 57.8% amino 
acid identity. Phylogenetic analysis suggests that both genes   
belong to the apo2 subfamily (Fig. S1 B). With the exceptions 
of apo2b and a gene related to AID, no further members of the 
apo gene family were identified in the zebrafish genome.
We first examined the expression pattern of apo2b mRNA 
by in situ hybridization of whole embryos. Expression of 
apo2b was detected in the skeletal muscles of the head, in so-
mitic muscles, and in the heart (unpublished data), a pattern 
identical to that of apo2a. Because apo2a and apo2b share se-
quence similarity and both are expressed in the muscle of the 
zebrafish embryo, we next investigated if Apo2b also interacts 
the chevron-shaped myosepta (Fig. 4 D). At 72 hpf, immuno-
labeling  of  -dystroglycan  revealed  gaps  or  bifurcations  in 
these structures in the morphants (Fig. 4, E and F). Moreover, 
the myosepta were not as straight and were more U-shaped (Fig. 4, 
E and F) in comparison with the chevrons of control embryos 
(Fig. 4 D). Other proteins of the DGC, such as dystrophin and 
-sarcoglycan, showed the same defective patterns in apo2a 
morphants (unpublished data). Examination of laminin, an extra-
cellular matrix component of the myoseptum, also revealed 
disrupted and bifurcated somite boundaries in the morphants   
(Fig. 4, G and H), which suggests that the integrity of the entire 
myoseptum is disturbed.
To correlate these defects of the myosepta with the cell-
free spaces and giant fibers observed under DIC optics, mor-
phants  and  controls  were  costained  with  antibodies  directed 
against -dystroglycan and slow muscle myosin (Fig. 4, I–K). 
Cell-free spaces did not always correlate with the disruption of 
the myoseptum (Fig. 4 K, star), which suggests that they arise 
independently of the gaps in the myosepta. Some muscle fibers 
were detached from the myoseptum (Fig. 4 K, arrow). At places 
where myosepta were disrupted, giant slow myosin fibers were 
frequently  observed  that  spanned  the  length  of  two  somites   
(Fig. 4 J, arrowhead). Formation of these extra-long fibers was 
not restricted to the superficial slow muscles: immunostaining 
of fast myosin and sarcomeric actin also confirmed the presence 
of giant fibers (unpublished data) and of enlarged intercellular 
spaces (Fig. 4, L and M) in the fast muscles. Instead of being 
Figure 4.  Apo2a morphants have defective myosepta and form intersomitic giant myofibers. (A–C) DIC images of Mo(ATG)-apo2a–injected embryos. 
Mo(ATG)-apo2a morphants (Mo) exhibit cell-free spaces in the somites (A and B, stars), disrupted myosepta (B and C, arrows), and giant myofibers that 
span two somites (C, arrowhead). (D–F) Immunohistochemistry with antibodies directed against myoseptal proteins reveals defects in the myosepta of 
apo2a morphants: -Dystroglycan (DG) staining of control (cont; D) and Mo(ATG)-apo2a–injected (Mo; E and F) embryos (white arrows, disrupted myo-
septa; green arrows, split myosepta). (G and H) Laminin staining reveals abnormal myosepta in Mo(ATG)-apo2a morphants (H) compared with wild type 
(G). Green arrows, split myosepta. (I–K) Double immunohistochemistry with anti–-dystroglycan (DG) and the anti-slow muscle myosin antibody F59 reveals 
giant slow muscle myofibers (J, arrowhead) crossing the somite boundary (J, arrow). (I) Control embryos never show these intersomitic myofibers. Detach-
ment of myofibers from the myosepta (K, arrow) generates cell-free spaces (K, star). (L and M) Sarcomeric myosin stained with A4.1025 in Mo(ATG)-apo2a 
morphants shows detached slow fibers (M, yellow arrows) overlaying fast fibers and generating cell-free areas inside the muscle tissue (star). Most of the 
fast fibers are still anchored to the myosepta. A few fast fibers have also detached (M, blue arrow). (L) Control. All embryos injected with Mo(ATG)-apo2a 
were coinjected with Mo-p53. Embryos are 72 h old. The anterior is shown to the left, dorsal side up. Bars, 25 µm.JCB • VOLUME 189 • NUMBER 3 • 2010   532
did not cause reduction of GFP expression, which indicates 
that Mo(ATG)-apo2b did not efficiently disrupt translation of 
Apo2a (unpublished data). When apo2b-gfp plasmids encod-
ing the Apo2b-GFP fusion protein were coinjected with the 
Mo(ATG)-apo2b, none of the double-injected embryos showed 
fluorescence (data not shown), which indicates that the mor-
pholinos do efficiently block translation of Apo2b. In parallel, 
Mo(ATG)-apo2a  injected  with  apo2b-gfp  plasmid  did  not 
block the expression of the Apo2b-GFP fusion protein (un-
published data). This strongly suggests that Mo(ATG)-apo2a and 
Mo(ATG)-apo2b morpholinos are specific to apo2a and apo2b 
mRNA, respectively.
Apo2a and Apo2b form heteromers
One possible explanation for the nonredundant function of 
Apo2a and Apo2b is that heteromeric complexes between 
the two proteins are required for function. To test whether 
Apo2a and Apo2b can form heteromers, we performed pull-
down  experiments  with  GST-tagged Apo2a  or Apo2b  with 
GFP-labeled Apo2b (Fig. 6 A). No complexes formed when 
GST-Apo2a was incubated with GFP alone (Fig. 6 A, lane 2). 
However, when GST-Apo2a was incubated with Apo2b-GFP, 
a band of the expected size for the chimeric protein was pulled 
down (Fig. 6 A, lane 3). Thus, Apo2a and Apo2b can form 
with Unc45b. Pull-down assays performed with GST-Apo2b   
and Unc45b-GFP showed that Apo2b can indeed also interact 
with Unc45b (Fig. 5, B and C, lane 1). Furthermore, this inter-
action was mediated by the central and UCS domains of Unc45b 
(Fig. 5 C, lanes 2–4 and 6). As in the case of Apo2a, neither the 
TPR-GFP chimera nor GFP alone interacted with GST-Apo2b 
(Fig. 5 C, lane 5; and not depicted).
We next tested the function of apo2b by injecting morpho-
linos designed against the region spanning the start codon or the 
region further 5 in the untranslated sequences. Both morphants 
showed reduced mobility and decreased birefringence (79.8% 
morphants, n = 200) compared with control embryos (Fig. 5, 
D–G). In addition, the heart rate was reduced and the blood cir-
culation was impaired (unpublished data). Immunohistological 
analysis of the muscle structure revealed the same defects as 
those observed with apo2a morpholinos: detachment of fibers, 
interrupted myosepta, which are often associated with giant myo-
fibrils, and cell-free cavities in the somites (Fig. 5, H–K). The 
results of these knockdown experiments suggest that the two 
apo2 genes cannot compensate for one another.
Although  unlikely,  as  the  sequences  are  very  dissimi-
lar, we wished to exclude the possibility that the morpholinos 
cross-react with the two apo2a and -2b mRNAs. Co-injection 
of  the  apo2a-gfp  plasmid  and  Mo(ATG)-apo2b  morpholinos 
Figure 5.  Apo2b interacts with Unc45b. (A) Schematic diagram of the Unc45b-GFP full-length and deletion proteins used in pull-down assays.   
(B and C) Western blot of in vitro translated input (B) and Unc45b-GFP proteins pulled down with GST-Apo2b (C). Fusion proteins were detected with an 
anti-GFP antibody. With the exception of Unc45b-TPR (lane 5), all the other fusions proteins were pulled down by Apo2b-GST (lanes 1–4 and 6), which 
indicates that both the central as well as the UCS domain can mediate the interaction with Apo2b. Lane 7 shows size markers. Note that relative to   
protein inputs in binding assays (B), 10-fold less protein was loaded onto the control gels shown in C. White boxes indicate 95 kD. (D and E) Control (D)   
and Mo(ATG)-apo2b (E)-injected embryos. Injection of the morpholino complementary to sequences surrounding the ATG of apo2b mRNA reduces the 
birefringence of the skeletal muscle. (F and G) Control (F) and Mo(UTR)-apo2b (G)-injected embryos. The morpholino complementary to the 5 UTR of 
the apo2b mRNA reduces the birefringence of the skeletal muscle in a similar manner to the morpholino directed against the ATG of apo2b mRNA. The 
striking similarity of this phenotype to apo2a morphants suggests that the two Apo2 proteins do not act redundantly. (H and I) Mo(ATG)-apo2b morphants 
(I) but not controls (H) observed with DIC optics have cell-free spaces in the somites (I, stars). (J and K) Double immunohistochemistry with a slow muscle 
myosin antibody F59 and/or an -dystroglycan (DG; J and K, respectively) antibody reveals extra-long intersomitic myofibers spanning two somites   
(K, arrowhead), detached myofibers, and defective myosepta in the morphants (K; white arrow, disrupted myosepta; yellow arrow, detached fibers). 
(I) Control. Bars: (D, E, and H–K) 30 µm; (F) 80 µm; (G) 100 µm.533 Lack of Apobec2 causes dystrophy • Etard et al.
same myofiber-free areas within the muscle structure (Fig. 7,   
A and B; 100%, n = 10 embryos), a result confirmed by the 
use of DIC optics (Fig. 7, D and E; n = 10 embryos). More-
over, fibers were also detached from the myosepta in unc45b 
mutants (Fig. 7 G, arrows). Immunohistochemistry using the 
anti–-dystroglycan antibody revealed broader and bifurcated 
myosepta in unc45b mutants compared with wild-type em-
bryos (Fig. 7, I and H), which indicates that the myosepta are 
also disrupted.
We also examined hsp90a mutants, which, like unc45b 
mutants, fail to form myofibrils (Etard et al., 2007; Hawkins 
et al., 2008). Cell-free spaces were not detectable in hsp90a 
mutants, and the myosepta were structured as in wild-type   
embryos (Fig. 7, C and F; n = 20 embryos). In contrast to unc45b 
mutants, hsp90a mutants have a beating heart. To exclude the 
possibility that the cell-free spaces and disrupted myosepta in 
apo2a  morphants  and  unc45b  mutants  result  from  impaired 
blood circulation, we examined the myosin light chain gene 2  
(mlc2) mutant, whose heart does not beat (Rottbauer et al., 
2006). The homozygous mlc2 mutants did not exhibit cell-free 
spaces in the somitic muscle, showing that the absence of blood 
flow cannot account for the observed phenotype (unpublished 
data, n = 10 embryos).
We have previously reported that a chimeric Unc45b-
GFP protein is localized at the Z line in undamaged muscle 
(Etard et al., 2008). Given the unexpected myoseptal pheno-
type of unc45b mutants, we reexamined the location of Unc45b-
GFP protein after injection of an unc45b-gfp plasmid in wild-type 
embryos. This protocol results in a strong mosaicism of ex-
pressing cells, permitting the study of individual labeled cells 
in a background-free environment in the intact embryo. As 
previously noted, the fusion protein localized to the Z line.   
In addition, we also found accumulation at the myoseptal bound-
ary of expressing cells (Fig. 7 J, blue arrow). We also raised an 
antibody against zebrafish Unc45b and examined the location 
of the endogenous protein. As in the case of the fusion protein, 
endogenous Unc45b accumulated at the Z line. In addition, we 
also noted an enrichment of Unc45b immunoreactivity at the 
myoseptal boundary (Fig. 7 K, blue arrow). We also studied 
the localization of CapZa1-GFP fusion protein (Schafer et al., 
1993; Papa et al., 1999) to assess whether Z line proteins in 
general are enriched at the myoseptal boundary. The CapZa1-
GFP fusion protein was enriched at the Z line, but it showed 
only very low levels at the myoseptal boundary (Fig. 7 L). 
Collectively, the location of the Unc45b protein at the myo-
septal boundary supports a role for Unc45b in myofibril attach-
ment, as suggested by the phenotype of unc45b mutants. To assess 
whether the localization of Unc45b is affected by a lack of 
Apo2a proteins, Mo(ATG)-apo2a and Mo(ATG)-apo2b were 
injected together with a plasmid encoding unc45b-gfp. Unc45b-
GFP  localization  appeared  unaffected  in  the  morphants   
(unpublished data).
Apo2 fusion proteins are localized to the 
myoseptal boundary
To  compare  the  intracellular  localization  of  Apo2  proteins 
with that of Unc45b, we generated fusion proteins by linking   
heteromeric complexes. GST-Apo2b was also able to interact 
with Apo2b-GFP (Fig. 6 A, lane 6), whereas an interaction 
with GFP alone was not noticeable. This suggests that Apo2b 
can also form homomeric complexes. The formation of both 
homomeric as well as heteromeric complexes could also be 
demonstrated for GST-Apo2a or GST-Apo2b and MYC-Apo2a 
chimeras (Fig. 6 B). In summary, these data support the no-
tion that Apo2a and Apo2b can form heteromeric complexes 
in addition to the homomeric complexes suggested previously 
(Prochnow et al., 2007).
apo2 morphants share phenotypic traits 
with unc45b mutants
The most striking phenotype of unc45b mutants is the severe 
disruption of the myofibrils, presumably caused by a failure of 
the myosin heavy chains to fold properly (Etard et al., 2007). 
We did not observe such a phenotype in the apo2a morphants, 
which suggests that apo2a does not have a function in the gen-
esis of myofibrils. However, if the interaction of Unc45b and 
Apo2a has any functional relevance in the muscle, one would 
predict that the more subtle defects seen in apo2a morphants 
would also be evident in unc45b mutants. Close examination 
of -actin-GFP transgenic unc45b mutants indeed revealed the 
Figure 6.  Apo2a and Apo2b can form homo- and heteromers. (A) GST-
Apo2a and GST-Apo2b fusion proteins can pull down Apo2b-GFP proteins. 
Pulled-down proteins were detected by Western blotting with an anti-GFP 
antibody. Lanes 1 and 4: protein size markers (white boxes indicate 95 kD);   
lanes 2 and 5: GFP-only controls; lane 3: pull-down of Apo2b-GFP by 
GST-Apo2a;  lane  6:  pull-down  of  Apo2b-GFP  by  GST-Apo2b;  lane  7: 
Apo2b-GFP protein input. (B) GST-Apo2a and GST-Apo2b can pull down 
MYC-Apo2a fusion proteins as revealed by Western blotting with the anti-
MYC epitope 9E10 antibody. Lane 1: pull-down of Apo2a-MYC with GST-
Apo2a; lane 2: protein size markers (white boxes indicate 72 kD); lane 3: 
input of MYC-Apo2a protein; lane 4: GST-only control; lane 5: pull-down 
of MYC-Apo2a by GST-Apo2b.JCB • VOLUME 189 • NUMBER 3 • 2010   534
(Etard et al., 2008; unpublished data). This suggests that Apo2 
proteins have a tendency to aggregate at high levels. In addition, 
the Apo2 fusion proteins lose their characteristic subcellular local-
ization when expressed in unc45b
/ embryos (Fig. 8, J and K). 
These punctuate aggregates in the mutant also form in cells that 
express only low levels of fusion protein, which suggests that in 
these cases, it is not caused by overexpression but rather indi-
cates a requirement for Unc45b in the correct localization of 
Apo2 proteins.
Discussion
We have identified and characterized Apo2 proteins as inter-
action partners of Unc45b, and we have shown that lack of 
function of the Apo2 proteins causes defects in myoseptal 
structure of the developing skeletal muscle of the embryo. 
This interaction is specific for Unc45b and does not include 
Hsp90a, which is known to cooperate with Unc45b in myo-
fibrillogenesis. This role of Unc45b and Apo2 proteins in myo-
septal formation and integrity represents a novel function of 
Unc45b that is distinct from Unc45b’s well-established role 
in myofibrillogenesis.
Embryos lacking apo2 function have a 
dystrophic phenotype
Embryos in which Apo2a or Apo2b were knocked out showed 
muscle disorders that resemble those of mutations in DGC genes   
(Parsons et al., 2002; Bassett et al., 2003; Guyon et al., 2005; 
mOrange1 fluorescent protein (Shaner et al., 2004) to the   
C terminus of the cDNA of Apo2a and Apo2b. The fusion pro-
teins were expressed under the control of the muscle-specific 
unc45b promoter in a mosaic fashion. The localization of the 
fusion proteins was analyzed in 4–5-d-old larvae.
In addition to a low-level distribution in the cytoplasm, we 
could detect enrichment of the Apo2a-mOrange1 protein at the 
myoseptal boundaries (Fig. 8, A and B). In this region, the ex-
pression clearly overlapped with that of Unc45b (Fig. 8 C and 
Fig. 7, J and K). When mOrange1 was expressed by itself with-
out being fused to Apo2a, we did not detect this distribution 
(unpublished data). Interestingly, the Apo2b–mOrange fusion 
protein was distributed in a similar but not identical pattern.   
Although Apo2b-mOrange1 was expressed at lower levels at 
the myoseptal boundary, it was strongly enriched at the Z line of 
the myofibril (Fig. 8, D and E), colocalizing with Unc45b at this 
structure (Fig. 8 F).
The injection/expression protocol we used normally re-
sults in different levels of expression in individual myofibers 
even in the same embryo. Cells expressing Apo2a-mOrange1 or 
Apo2b-mOrange1 fusion proteins at high levels always formed 
large aggregates of fluorescence in the cytoplasm (Fig. 8 G). 
These cells also showed defects in striation (Fig. 8, H and I), 
which suggests that high levels of Apo2 proteins impair the 
formation of myofibrils. Such protein aggregates were not 
observed when high levels of mOrange1 alone or other fu-
sion proteins such as Unc45b-GFP or Hsp90a-GFP were ex-
pressed in zebrafish embryos using the same expression systems   
Figure 7.  unc45b mutants also exhibit cell-free spaces in the somites and disruption of the myosepta like the apo2a morphants. (A–C) -Actin–GFP 
transgenic wild-type (A), unc45b (B), and hsp90a (C) mutant embryos. unc45b mutant embryos exhibit cell-free spaces in the somitic musculature (B, stars)   
as seen in apo2a morphants. In contrast, wild-type siblings (A) and hsp90a (C) mutants do not show these gaps. (D–F) Cell-free spaces are also visible 
in unlabeled unc45b mutants using DIC optics (E, white stars). In contrast, wild-type siblings (D) and hsp90a mutants (F) do not exhibit these cell-free 
spaces in the somites. Broken lines indicate myoseptal boundaries. (G) Merge of DIC and -actin–GFP fluorescence frames shows detachment of myo-
fibrils (arrows) and cell-free spaces (stars) in unc45b mutants, which is seen in apo2a morphants but never seen in wild-type or morphant control embryos.   
(H and I) Immunohistochemistry with a -dystroglycan (DG) antibody shows disruption of myosepta in unc45b mutants (I), whereas wild-type siblings (H) 
have normal chevron-shaped myosepta. (J–L) Unc45b-GFP is localized at the Z line (J, white arrow) as well as at the myosepta (blue arrow), whereas   
embryos expressing CapZa1-GFP show localization at the Z line exclusively (L, arrow). Immunohistochemistry with an antibody against endogenous 
Unc45b reveals that endogenous Unc45b is localized at the myosepta (K and K, blue arrows) in addition to the previously shown Z line staining (K, white 
arrow). Bars: (A–I and K) 40 µm; (J and L) 2 µm; (K): 4 µm.535 Lack of Apobec2 causes dystrophy • Etard et al.
is weakened in the morphants. Gaps in the myosepta were fre-
quently correlated with the presence of giant fibers that span 
two somites. It has previously been shown that in the absence 
of normal somite boundaries, muscle cell progenitors elongate 
until they reach the next intact myoseptum (Henry et al., 2005). 
It is thus conceivable that the myoseptal defects already ex-
isted before the onset of contractions of the somitic muscle. 
In agreement with this idea, unc45b mutants, which are com-
pletely paralyzed from early stages of development, also show 
fiber detachment.
In  addition  to  skeletal  muscle,  apo2a  and  apo2b  tran-
scripts were detected in the heart. Morphants showed reduced 
heart rates and developed pericardial edema, which suggests 
Cheng et al., 2006) and in genes that are involved in myoseptal 
integrity (Kudo et al., 2004; Raeker et al., 2006; Hall et al., 
2007). For example, apo2a and apo2b morphants had impaired 
mobility and displayed cell-free spaces in the somites, just as 
the dystrophin-deficient sapje (Bassett et al., 2003) and the 
laminin-2–deficient candyfloss mutant (Hall et al., 2007). 
These cell-free spaces are either the result of failed attachment 
during development or are caused by rupture of the attachment 
of the myofiber (Hall et al., 2007). The vertical myosepta, 
which are part of the connective tissue that transmits the force 
between the contractile units of each somite, were split apart at 
places. This suggests that not only the attachment of myofibrils 
to the myoseptum, but also the integrity of the myoseptum itself, 
Figure 8.  Localization of Apo2a and Apo2b fusion proteins. (A–C) Mosaic expression of Apo2a-mOrange1 fusion proteins in individual cells of the skel-
etal muscles. Cells expressing Apo2a-mOrange1 at low levels show enrichment of the fusion proteins at the myoseptal boundary (A and B, arrowheads). 
Low levels and more diffuse staining are present in the cytoplasm and over the myofibril. Enrichment of Apo2a-mOrange1 at the myoseptal boundary 
overlaps with Unc45b-TFP (C, arrowhead). (D–F) Mosaic expression of Apo2b-mOrange1 fusion proteins in individual cells of the skeletal muscles. Diffuse 
staining in the cytoplasm and in a striated manner at the Z line of the myofibrils was noted for this fusion protein. Apo2b–mOrange is colocalized with 
Unc45b over the Z line and also at the myoseptal boundary (D and F, arrowhead) in cells coexpressing Unc45b-TFP fusion protein (C). (G–I) Expression of 
Apo2a-mOrange1 at high levels results in aggregation of the protein in the cytoplasm (G). This results in loss of striation in highly expressing cells (H and I,   
arrows; overlay of G and H). (J and K) Lack of Unc45b protein leads to aggregation of Apo2a-mOrange1 (J) and Apo2b-mOrange1 fusion proteins.   
Bars: (A, C, D, and F) 16 µm; (B, E, J, and K) 4 µm; (G, H, and I) 10 µm.JCB • VOLUME 189 • NUMBER 3 • 2010   536
completion (Srikakulam and Winkelmann, 2004). Our findings 
indicate that Unc45b, probably via its interaction with Apo2, 
also plays a role in myofibril attachment to the myoseptum.
In mature myofibrils, Unc45b was found to be enriched at 
the Z line, whereas the cytoplasm of the myofibers contained 
lower levels of the chaperone (Etard et al., 2008). Here, we 
show that Unc45b is not only enriched at the Z line, but that 
high levels of Unc45b are also detected in the cytoplasm imme-
diately adjacent to the myosepta. In this region, high levels 
of Apo2a and to a lesser degree also Apo2b fusion proteins   
are found. In addition, Apo2b-mOrange1 is enriched over the   
Z lines. Thus, Apo2 proteins colocalize to subcellular sites with 
high levels of Unc45b protein, in line with the notion of a direct 
interaction between the Apo2 and Unc45b proteins.
The  sub-myoseptal  cytoplasm  is  also  enriched  for  the 
mRNAs of DGC proteins (Bolaños-Jimenez et al., 2001), which 
suggests that this subcellular region is an active site of protein 
synthesis. A straightforward interpretation of our results is that 
the Apo2 proteins and possibly other myoseptal proteins are 
clients of the chaperone Unc45b, requiring Unc45b for cor-
rect folding. In agreement, Apo2 fusion proteins tend to form 
cytoplasmic aggregates when expressed at high levels in mus-
cle cells of wild-type embryos. However, it cannot be excluded 
that the proteins act in complexes that have different func-
tions; for example, directly maintaining the integrity of the 
myoseptal junction.
The role of Apo2 proteins
Apo2a and 2b are highly related and coexpressed in the skeletal 
and cardiac muscles. Both of them interact with Unc45b. The 
phenotype of the Apo2a and -2b morphants suggests that the 
two proteins act in the same pathway, but in a nonredundant 
fashion. The absolute levels of Apo2a and Apo2b proteins may 
be critical; however, knockdown of both proteins simultane-
ously does not increase the severity of the phenotype (un-
published data). Analysis of the crystal structure of human Apo2 
suggests  that  the  proteins  form  tetramers  (Prochnow  et  al., 
2007). Hence, an alternative explanation for the nonredundant 
action of the two Apo2 proteins could be that they function in 
the context of heteromeric complexes composed of Apo2a and 
Apo2b subunits. In support of this notion, our pull-down experi-
ments suggest that the two Apo2 proteins can indeed form 
heteromeric complexes.
Apo proteins contain the active site of the cytidine de-
aminases ([H/C]-[A/V]-E-[X]24-30-P-C-[X]2-C), in common with 
other members of the family (Navaratnam and Sarwar, 2006). 
This motif is also present in zebrafish Apo2 proteins and the 
Apo2 homologues of other species. It is, however, unclear 
whether Apo2 subfamily members act indeed as deaminases 
(Liao et al., 1999; Mikl et al., 2005). In contrast to Apo3 pro-
teins, Apo1 has a very high substrate specificity (Blanc and 
Davidson, 2003). Only a few mRNA substrates in addition to 
the apolipoprotein mRNA have been described so far (Skuse   
et al., 1996; Yamanaka et al., 1997). Interestingly, mammalian 
Apo2 inhibits the deaminase activity of Apo1 on apolipopro-
tein mRNA (Anant et al., 2001). This suggests that Apo2 pro-
tein can interfere with the formation or function of the Apo1 
that Apo2a and -2b also have a function in the heart. It remains 
to be established whether adhesion of myocardiocytes is af-
fected by lack of Apo2a/b function in the same manner as skel-
etal myocytes.
This is the first report ascribing a function to Apo2-like 
genes in any organism. Histological examination of heart and 
calf muscles of Apo2 knockout mice did not reveal any abnor-
malities (Mikl et al., 2005). The Apo2 subgroup appears to 
contain the most ancient members of this DNA/RNA-editing   
enzyme family, as it is present throughout the vertebrate lin-
eage. In contrast, the Apo1 and Apo3 subgroups seem to be   
restricted to mammals (Conticello et al., 2005). It is possible 
that Apo1 or -3 act redundantly with Apo2 in the heart and skel-
etal muscle of mammals. The zebrafish model thus provides a 
powerful tool to test the function of apo2 in the potential ab-
sence of redundancy. Also, given the fact that the mutations 
in DGC genes generally present pathological defects much later   
in the ontogeny of mammals than in fish development, the phe-
notype may be subtle and may have been overlooked in the 
knockout mice. In light of the fact that so far only half of human 
congenital myopathies can be assigned to a specific gene defect 
(North, 2008; Sewry et al., 2008), our work identifies Apo2a 
and -2b as well as Unc45b as novel disease candidates for human 
muscular dystrophies.
The myosin chaperone Unc45b interacts 
with Apo2a and Apo2b
Both Apo2 proteins interact with the chaperone Unc45b. Multi-
ple lines of evidence suggest that this interaction is specific, 
and that it delineates a novel function for Unc45b, distinct 
from the myosin folding pathway that it has previously been 
implicated in (Barral et al., 2002; Srikakulam and Winkelmann, 
2004; Etard et al., 2007). As a prerequisite for any physical   
interaction, unc45b, apo2a, and apo2b are indeed coexpressed 
in the muscles of the skeleton and the heart. The Apo2a protein 
interacts with Unc45b in the yeast two-hybrid screen, and both 
Apo2a and Apo2b pull down Unc45b in in vitro assays. This 
interaction was not observed for Hsp90a and related chaperone 
proteins, which suggests that the interactions of Apo2a and -2b 
are restricted to the chaperone Unc45b. These interactions of 
Apo2a and 2b with Unc45b require the central and the UCS 
domains of Unc45b and are not mediated by the TPR domain 
of Unc45b, which is an Hsp90 interaction domain. Mutants of 
unc45b showed phenotypic traits that resemble the dystrophic 
phenotype seen in apo2a and apo2b morphants. Specifically, 
they exhibited cell-free spaces in the somites and myoseptal 
defects, and their myofibers were found to be detached from 
the myosepta. These defects were not observed in hsp90a mu-
tants. Together with the fact that Hsp90a protein did not interact 
with Apo2 proteins in vitro, this underscores the notion that the 
Unc45b/Hsp90a and Unc45b/Apo2 interactions represent dis-
tinct pathways. This suggests a role for Unc45b that is different 
from myofibrillogenesis, the only hitherto known biochemical 
function  of  Unc45b  in  zebrafish.  During  myofibrillogenesis, 
Unc45b functions as a co-chaperone that in concert with Hsp90 
folds the myosin heavy chain into a functional conformation. 
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Glu + Pro + Arg + Ala + 3(4Gly + Ser). In both cases, the start codon of 
the fluorescent protein was removed. The fusion proteins were expressed 
under the highly muscle-specific zebrafish Unc45b promoter.
For the synthesis of in situ hybridization probes, we used the full-
length apo2 cDNAs cloned into the pGEM-T Easy Vector System (Promega). 
All constructs were verified by sequencing.
Histology, immunohistochemistry, in situ hybridization, and microscopy
We performed whole-mount in situ hybridization and immunohistochem-
istry as described previously (Crow and Stockdale, 1986; Oxtoby and 
Jowett, 1993; Costa et al., 2002). We used monoclonal antibodies di-
rected against slow muscle myosin (F59, (Crow and Stockdale, 1986), 
sarcomeric myosin (A4.1025, 1:100; Developmental Studies Hybridoma 
Bank  [DSHB],  University  of  Iowa),  -sarcoglycan  (1:100  Novocastra;   
Leica), laminin (1:60; Sigma-Aldrich), and -dystroglycan (1:60; Sigma- 
Aldrich), and the anti Myc-epitope antibody 9E10 (1:25; DSHB). Antibodies   
for Unc45b were produced by injection of rabbits with the following 
peptide: GVSLLKEMYKKTKN (BioGenes). This peptide is unique in the 
zebrafish genome (Zebrafish Gene Collection release Zv7). For anti-Unc45b 
staining, fish were fixed at 20°C in DMSO/methanol (1:5) for 2 h.
Anti–mouse or –rabbit IgG Cy3-conjugated secondary antibodies 
were used for fluorescent detection (1:1,000; Sigma-Aldrich).
A confocal microscope (TCS SP2) and the accompanying software 
(LCS; both from Leica) were used to analyze antibody staining and fusion 
protein localization. For visualization of fusion proteins, living zebrafish 
larvae were immobilized with 0.02% 3-aminobenzoic acid methylester   
(MESAB; Invitrogen), immersed in a water droplet on a microscopy slide, 
and imaged with a dip-in 63× objective lens (0.90 NA, HCX Apochro-
mat water; Leica). 458-nm and 476-nm laser lines were used for mTFP1 
excitation; 488 nm was used for GFP excitation and 514 nm was used 
for mOrange1 excitation. The observations were performed at 22°C.   
Birefringence  was  analyzed  with  a  microscope  (MZ16F;  Leica)  as   
described previously (Behra et al., 2002). Image editing was limited to 
minimal sharpening and exposure adjustment.
Protein pull-down experiments
Expression of GST-Apo2a and GST-Apo2b recombinant proteins was in-
duced in BL21D3 cells by adding 1 mM IPTG at OD600 = 0.8. After incuba-
tion for 4 h at 30°C, proteins were extracted by sonication in lysis buffer 
(1× PBS, 0.1% Triton X-100, 1 mM DTT, and 0.5 mM phenylmethylsulfonyl 
fluoride). For pull-down experiments, the bacterial protein lysates were in-
cubated for 1 h at 4°C with beads coated with the tripeptide glutathione 
(GE Healthcare). The beads were pelleted for 1 min at 550 g and washed 
three times with TEN buffer (10 mM tris/HCl, pH 7.4, 150 mM NaCl, 
0.5% nonidet P40, and 1 mM EDTA). Unc45b-GFP and all the deletion 
variants as well as MYC-Apo2a and Apo2b-GFP proteins were synthesized 
in rabbit reticulocyte lysate (TNT kit; Promega). 15 µl of the TNT lysate was 
incubated at room temperature for 1 h with glutathione-sepharose–coupled 
proteins. After three successive washes, bound proteins were detached 
from the beads by boiling for 10 min at 95°C with 20 µl of 5× SDS-PAGE 
sample buffer (0.5M Tris/HCl, pH 6.8, 10% [wt/vol] SDS, 20% glycerol, 
0.0025% pyronin Y, and 25% -mercaptoethanol). Proteins were sepa-
rated by 10% SDS-PAGE, transferred onto a nitrocellulose filter, and incu-
bated with different primary antibodies (1:5,000 GFP [Torrey Pines Biolabs, 
Inc.] or 1:500 MYC [9E10; DSHB]) for one night at 4°C. After washing 
three times, a secondary antibody (goat anti–rabbit Alexa Fluor 680 for 
GFP and goat anti–mouse Alexa Fluor 680 for MYC; Invitrogen) was ap-
plied for 1 h at room temperature. Blots were visualized using an infrared 
imaging system (Odyssey; LI-COR Biosciences).
Microinjections
Injections were performed as described previously (Müller et al., 1999). 
In brief, zebrafish eggs were collected shortly after being laid. Cleaned 
eggs were transferred to a Petri dish with a minimal amount of water. 
Embryos were injected (FemtoJet; Eppendorf) through the chorion into the 
yolk compartment at the one-cell stage. Injection needles were pulled from 
borosilicate glass capillary tubes with filament (Warner Instruments) using 
a micropipette puller (Sutter Instrument Co.). Plasmid DNA was purified 
with the Plasmid Maxi kit (QIAGEN) and diluted in water to 20–50 ng/µl   
for injection. Phenol red was added to the DNA and RNA samples 
before injection (0.1% final concentration). Morpholinos (Gene Tools, LLC) 
were injected at the following concentrations: 0.2 mM Mo(ATG)-apo2  
(5-TGCTGCCCTTTCTATCGGCCATCTC-3), 0.2 mM Mo(ATG)-apo2a-contr  
(5-TGCTCCCGTTTGTATCCGCGATCTC-3),  1.6  mM  Mo(UTR)apo2a  
(5-ACACACCTCAGTATTTATAACAGC-3),  0.5  mM  Mo-p53  (Robu  et  al.,   
2007), 0.6 mM Mo(ATG)-Apo2b (5-CTTGCTGTCCTTTTTGTCTGCCATG-3), 
protein–mRNA complex. Unfortunately, the recognition sequence 
of the Apo1 complex is so degenerate and short that a search of 
the zebrafish genome with the mammalian Apo1 recognition 
sequence did not yield significant results (unpublished data). 
The precise targets of Apo2a and -2b thus remain a mystery. 
Our work, however, implicates the mRNAs of myoseptal pro-
teins as potential targets. It has recently been demonstrated that 
splicing of minor-class introns occurs in the cytoplasm, which 
indicates that RNA processing is not restricted to the nucleus 
(König et al., 2007). Thus, Apo2a and -2b proteins may have a 
function in cytoplasmic RNA editing or repair, modifying or 
maintaining the large mRNAs of the proteins that form the 
DGC. Alternatively, Apo2a and Apo2b proteins could interact 
with Unc45b and other myoseptal proteins to establish/main-
tain the integrity of the myoseptum. Irrespective of the precise 
targets, our work has uncovered a novel interaction between 
the myosin chaperone Unc45b and Apo2 proteins, and has im-




Fish were bred and raised at 28.5°C as described previously (Westerfield, 
1993). unc45b




u45) have been described previously (Etard et al., 2007, 
2008; Hawkins et al., 2008). The mlc2 mutant was a gift of S. Just and   
W. Rottbauer (Otto Meyerhof Zentrum, Heidelberg, Germany; Rottbauer 
et al., 2006). The AB wild-type line (University of Oregon, Eugene) was 
used for all the experiments, and the mutations were also kept in this back-
ground. Sexually mature fish were crossed in couples, and eggs were 
collected after being laid. For experiments, fertilized eggs were raised in 
1× Instant Ocean salt solution (Aquarium Systems, Inc.) supplemented with 
200 µM 1-phenyl 2-thiourea (PTU) to suppress melanogenesis.
Two-hybrid screen
The  two-hybrid  interaction  screen  was  performed  by  Hybrigenics.   
In brief, full-length Unc45b protein was used as the bait, sub-cloned into 
pB27 as a C-terminal fusion with LexA, and then screened against a prey 
library cloned from 18–20-hpf zebrafish embryos. The yeast two-hybrid 
library is based on 10 million primary clones and was screened with 
9.8× coverage.
Cloning
The construction of unc45b-gfp and the truncated variants has been de-
scribed previously (Etard et al., 2008). In summary, all the unc45b-gfp 
expression constructs were cloned into the pCS2+gfp vector, to the N ter-
minus of GFP. The expression is driven by a cytomegalovirus promoter. 
Apo2a  cDNA  (Zebrafish  Gene  Collection,  110762,  seventh  assembly 
[Zv7]) was obtained from Hybrigenics (see Two-hybrid screen). 5 and 3 
rapid amplification of cDNA ends (RACE) PCRs were performed to clone 
the full-length coding sequence (FirstChoice RLM-RACE kit; Applied Bio-
systems). For construction of myc-apo2a and apo2a-gfp, the apo2a cDNA 
was amplified from cDNA obtained from 72-hpf embryos, and cloned 
into pCS2+ plasmids providing in-frame 5 myc tags and 3 gfp coding   
sequences, respectively.
The zebrafish genome was searched (Zebrafish Gene Collection   
release Zv7) for apo2a homologues by blasting the genome with the apo2a 
sequence. A sequence corresponding to apo2b was found (LOC567047). 
The apo2b cDNA was amplified with primers matching the apo2b gene. 
The resulting fragments were cloned into pCS2+gfp. For the generation 
of gst-apo2a and gst-apo2b, full-length cDNAs were cloned into the   
pGEX-4T-3 vector (GE Healthcare).
The  mOrange1  fluorescent  protein  was  fused  in  frame  with  the   
C terminus of Apo2a and -2b. We used a long flexible linker between the 
fluorescent protein and the cDNA of the gene of interest, which consisted of 
Ser + Arg + Ala + 3(4Gly + Ser). The mTFP1 fluorescent protein (Ai et al.,   
2006) was fused to the C terminus of Unc45b using the linker sequence JCB • VOLUME 189 • NUMBER 3 • 2010   538
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